SubHero Banner
Text

Fyarro (sirolimus protein-bound particles) (albumin-bound) – New orphan drug approval

November 23, 2021 - Aadi Bioscience announced the FDA approval of Fyarro (sirolimus protein-bound particles) (albumin-bound), for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

Download PDF